LENZ Therapeutics previously licensed Greater China rights to CORXEL for the development and commercialization of LNZ100 in April 2022.

A top-performing Greater China equity fund manager is sticking with his conviction call on big Chinese bank stocks listed in ...

ZEISS Group recently announced that Martin Fischer will officially take on the role of President and CEO of ZEISS Greater ...

Submission of NDA for LNZ100 in China by CORXEL Pharmaceuticals results in achievement of first milestone due to LENZ under the Development and Commercialization Agreement ...

Air France KLM announced the appointment of Steven van Wijk as General Manager Greater China, effective August 1, 2025. Mr.

Nestle said Tuesday its net profit fell in the first half of the year as the Swiss food giant behind Nespresso coffee ...

China plans to offer vouchers to elderly residents in a rare use of direct fiscal aid to tackle its rapidly aging population ...

Multiple foreign companies mentioned "China" and "Chinese market" during their earning calls and financial reports on ...

LENZ Therapeutics (NASDAQ:LENZ) said Monday that CORXEL Pharmaceuticals has submitted the new drug application for LNZ100 to the Center for Drug Evaluation of the National Medical Products ...

The 2025 World Artificial Intelligence Conference (WAIC), held from July 26 to 28 in Shanghai, brought together representatives from around the world to explore avenues for the inclusive growth of ...

The new office will lead and coordinate the Group’s commercial and investment activities across the country and the broader ...